help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feldman, R. S.
Right arrow Articles by Tashjian, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feldman, R. S.
Right arrow Articles by Tashjian, A. H., Jr
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCITONIN, SALMON
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*PARATHYROID HORMONE

Endocrinology, Vol 107, 1137-1143, Copyright © 1980 by Endocrine Society


ARTICLES

Effects of parathyroid hormone and calcitonin on osteoclast formation in vitro

RS Feldman, NS Krieger and AH Tashjian Jr

We have investigated hormonal interactions regulating bone resorption by measuring biochemical and morphological responses of neonatal mouse calvaria in vitro to treatment with 0.1 U/ml parathyroid hormone (PTH) without or with 100 ng/ml human calcitonin (CT). Calvaria were also labeled continuously with 0.5 microCi [3H]thymidine/bone. By 96 h, PTH stimulated the release of calcium (Ca) into the medium to 240% of control, while CT alone stimulated release of Ca to 96% of control. CT in the presence of PTH transiently inhibited the release of Ca up to 24- -48 h after its addition. The subsequent loss of responsiveness to CT has been described as escape. Light microscopic analysis showed that PTH treatment markedly increased the number of osteoclast profiles in parallel with the stimulation of Ca release. Ct in the presence of PTH only transiently slowed the increase in osteoclast profiles. Fewer osteoclast profiles were observed in the presence of CT alone than in the control. Autoradiography of PTH-treated bones first showed [3H]thymidine label in osteoclast nuclei at 24 h, which increased markedly by 96 h. In PTH- plus CT-treated calvaria, significantly fewer osteoclast nuclei were labeled even at 96 h. In summary, hormonally induced changes in osteoclast profiles correlated well with changes in the stimulated release of Ca from calvaria. PTH had at least two effects on cell kinetics: 1) an early effect to increase the number of osteoclasts by fusion of preexisting mononuclear osteoclast precursors, and 2) a later effect to increase the fusion of postmitotic mononuclear cells with osteoclasts. In parallel with the observation of escape, CT only transiently inhibited PTH-stimulated osteoclast formation. The transient inhibition by CT of PTH-stimulated resorption can be explained by an early effect on osteoclast precursor cell fusions.


This article has been cited by other articles:


Home page
EndocrinologyHome page
L. Rothe, P. Collin-Osdoby, Y. Chen, T. Sunyer, L. Chaudhary, A. Tsay, S. Goldring, L. Avioli, and P. Osdoby
Human Osteoclasts and Osteoclast-Like Cells Synthesize and Release High Basal and Inflammatory Stimulated Levels of the Potent Chemokine Interleukin-8
Endocrinology, October 1, 1998; 139(10): 4353 - 4363.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. Lorenzo and L. Raisz
Divalent cation ionophores stimulate resorption and inhibit DNA synthesis in cultured fetal rat bone
Science, June 5, 1981; 212(4499): 1157 - 1159.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society